NO20003108L - Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger - Google Patents
Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetningerInfo
- Publication number
- NO20003108L NO20003108L NO20003108A NO20003108A NO20003108L NO 20003108 L NO20003108 L NO 20003108L NO 20003108 A NO20003108 A NO 20003108A NO 20003108 A NO20003108 A NO 20003108A NO 20003108 L NO20003108 L NO 20003108L
- Authority
- NO
- Norway
- Prior art keywords
- melatonin
- pharmaceutical compositions
- preparation
- energetic
- ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9908019A FR2795323B1 (fr) | 1999-06-23 | 1999-06-23 | Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003108D0 NO20003108D0 (no) | 2000-06-16 |
NO20003108L true NO20003108L (no) | 2000-12-27 |
Family
ID=9547206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003108A NO20003108L (no) | 1999-06-23 | 2000-06-16 | Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1064941A1 (ru) |
JP (1) | JP2001026539A (ru) |
KR (1) | KR20010039680A (ru) |
CN (1) | CN1283455A (ru) |
AU (1) | AU4264800A (ru) |
BR (1) | BR0002772A (ru) |
CA (1) | CA2312432A1 (ru) |
EA (1) | EA002823B1 (ru) |
FR (1) | FR2795323B1 (ru) |
HU (1) | HUP0002377A3 (ru) |
MX (1) | MXPA00006145A (ru) |
NO (1) | NO20003108L (ru) |
NZ (1) | NZ505361A (ru) |
PL (1) | PL340954A1 (ru) |
ZA (1) | ZA200003165B (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050249785A1 (en) * | 2003-08-13 | 2005-11-10 | Gordon John G | Use of melatonin-containing oral supplement with animals |
CN1870992A (zh) | 2003-10-03 | 2006-11-29 | 维伊林股份有限公司 | 动物饲料组合物 |
DE60336934D1 (de) * | 2003-10-03 | 2011-06-09 | Veijlen N V | Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten |
EP1997488A4 (en) * | 2006-03-20 | 2010-04-21 | Takeda Pharmaceutical | AGENT FOR THE PREVENTION / TREATMENT OF IRRITABLE COLON SYNDROME |
ES2384798B1 (es) * | 2011-10-19 | 2013-06-04 | Universidad De Granada | Uso de melatonina para el tratamiento y/o prevención de la mucositis. |
RU2693044C1 (ru) * | 2018-05-28 | 2019-07-01 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеч | Способ профилактики нпвп-гастропатии |
WO2022157564A1 (en) * | 2021-01-23 | 2022-07-28 | Cellix Bio Private Limited | A pharmaceutical composition comprising famotidine, lidocaine and melatonin |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2729147A1 (fr) * | 1995-01-11 | 1996-07-12 | Adir | Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1999
- 1999-06-23 FR FR9908019A patent/FR2795323B1/fr not_active Expired - Fee Related
-
2000
- 2000-06-16 NO NO20003108A patent/NO20003108L/no not_active Application Discontinuation
- 2000-06-21 BR BR0002772-3A patent/BR0002772A/pt not_active IP Right Cessation
- 2000-06-21 PL PL00340954A patent/PL340954A1/xx not_active Application Discontinuation
- 2000-06-21 MX MXPA00006145A patent/MXPA00006145A/es unknown
- 2000-06-22 CA CA002312432A patent/CA2312432A1/fr not_active Abandoned
- 2000-06-22 NZ NZ505361A patent/NZ505361A/en unknown
- 2000-06-22 JP JP2000187435A patent/JP2001026539A/ja active Pending
- 2000-06-22 HU HU0002377A patent/HUP0002377A3/hu unknown
- 2000-06-22 EP EP00401781A patent/EP1064941A1/fr not_active Withdrawn
- 2000-06-22 EA EA200000568A patent/EA002823B1/ru not_active IP Right Cessation
- 2000-06-23 CN CN00122290A patent/CN1283455A/zh active Pending
- 2000-06-23 KR KR1020000034842A patent/KR20010039680A/ko not_active Application Discontinuation
- 2000-06-23 AU AU42648/00A patent/AU4264800A/en not_active Abandoned
- 2000-06-23 ZA ZA200003165A patent/ZA200003165B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2795323A1 (fr) | 2000-12-29 |
EA002823B1 (ru) | 2002-10-31 |
EA200000568A3 (ru) | 2001-02-26 |
CN1283455A (zh) | 2001-02-14 |
PL340954A1 (en) | 2001-01-02 |
NO20003108D0 (no) | 2000-06-16 |
HUP0002377A2 (hu) | 2002-05-29 |
HUP0002377A3 (en) | 2002-08-28 |
KR20010039680A (ko) | 2001-05-15 |
MXPA00006145A (es) | 2002-10-17 |
NZ505361A (en) | 2002-02-01 |
JP2001026539A (ja) | 2001-01-30 |
CA2312432A1 (fr) | 2000-12-23 |
FR2795323B1 (fr) | 2001-11-16 |
AU4264800A (en) | 2001-01-04 |
EA200000568A2 (ru) | 2000-12-25 |
ZA200003165B (en) | 2001-01-25 |
EP1064941A1 (fr) | 2001-01-03 |
BR0002772A (pt) | 2001-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20015782D0 (no) | Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri | |
TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
NO20003698L (no) | Orale sammensetninger | |
NO20013770L (no) | Metoder og blandinger for å öke antall hvite blodceller | |
HUP0002760A3 (en) | Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors | |
TNSN99171A1 (fr) | 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
ATE245977T1 (de) | Therapeutische substituierte guanidine | |
DE60032795D1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
DK0946157T3 (da) | Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte | |
NO964238L (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
NO20003108L (no) | Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger | |
ATE325803T1 (de) | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung | |
NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
NO993784L (no) | Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene | |
ATE296635T1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
IL118218A0 (en) | Terpenoidic derivatives and pharmaceutical compositions containing them | |
ATE273985T1 (de) | Ruthenium (ii) verbindungen in der krebsbehandlung | |
ATE314064T1 (de) | L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit | |
EA200000909A1 (ru) | ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА | |
RU97115054A (ru) | Средство для лечения онкологических больных |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |